Case report

An unusual cause of renovascular hypertension in a pediatric patient with chronic kidney disease

Piotr Skrzypczyk1Katarzyna Kanclerz2Aleksandra Ostrowska2Beata Leszczyńska1Przemysław Bombiński3Michał Brzewski3Małgorzata Pańczyk-Tomaszewska1
1Department of Pediatrics and Nephrology, Medical University of Warsaw, Warsaw, Poland
2Student Scientific Group at the Department of Pediatrics and Nephrology, Medical University of Warsaw, Warsaw, Poland
3Department of Pediatric Radiology, Medical University of Warsaw, Warsaw, Poland

Address for correspondence: Piotr Skrzypczyk, Department of Pediatrics and Nephrology, Medical University of Warsaw, ul. Żwirki i Wigury 63a, 02–091 Warszawa, Poland, tel: 502 507 822, fax: 22 317 99 54; e-mail: pskrzypczyk@wum.edu.pl

This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially

Abstract
Background: Renovascular hypertension (RVH) accounts for 5–10% of arterial hypertension in children and is most commonly caused by fibromuscular dysplasia. Sporadically, renal artery stenosis in pediatric patients is caused by extrinsic compressive masses.
Case report: A 12-year-old patient with complex urinary tract defect (dysplastic left kidney — nephrectomy at 11 months, right ectopic kidney in the midline, behind the urinary bladder), chronic kidney disease (CKD) stage 2, and arterial hypertension was admitted to the hospital due to worsening of kidney function during angiotensin-converting enzyme inhibitor (ACE-I) therapy. CT angiography revealed a right ectopic kidney located above the bladder, supplied by a single renal artery originating from the right common iliac artery. The renal artery had a tortuous shape with width in the ostium approx. 4.5 mm; then, the artery was bent and ran between the common iliac artery and the kidney. Ultrasound performed with a filled bladder showed bending and stenosis of the renal artery at the origin from the right common iliac — peak systolic velocity (PSV) 4.5–5.5 m/s and renal-aortic ratio (RAR) 3.1. With an empty bladder, no bending or stenosis was visible (PSV 1.7–1.9 m/s and RAR 1.0). Uroflowmetry revealed a dysfunctional micturition curve, large bladder capacity, and post-void urine retention. ACE-I was changed to beta-blocker and doxazosin, which led to blood pressure and kidney function normalization.
Conclusions: Renal ectopia associated with bladder dysfunction may result in renal artery stenosis causing renovascular hypertension.
Key words: renovascular hypertension; renal ectopia; chronic kidney disease; bladder dysfunction; adolescent
Arterial Hypertens. 2022, vol. 26, no. 2, pages: 92–97
DOI: 10.5603/AH.a2022.0009

Introduction

Arterial hypertension (AH) is a serious public health problem, as it is the most important risk factor of cardiovascular morbidity and mortality [1]. It affects about 3–5% of children and adolescents, and from puberty, its prevalence increases and occurs 3–4 times more often in boys than in girls [2]. Nowadays, due to the epidemy of obesity, sedentary lifestyle, and excessive dietary sodium intake, a significant increase in primary hypertension is observed [3]. However, in the pediatric population, secondary hypertension is still the leading cause, most often in the course of renal parenchymal diseases and renal artery stenosis [2–4].

Renovascular hypertension (RVH) comprises 5–10% of cases of pediatric hypertension [5]. The most common cause of RVH in pediatric patients is fibromuscular dysplasia in Europe and North America and Takayasu arteritis in Asia and Africa [6–8]. Other causes of RVH include renal artery thrombosis (e.g., as a consequence of renal artery catheterization), congenital stenosis/hypoplasia of the renal artery, neurofibromatosis type 1, tuberous sclerosis complex, Williams-Beuren, Alagille, and Grange syndromes, other forms of arteritis (e.g., polyarteritis nodosa), and extrinsic compressive masses [2, 5, 7–9]. Renal artery stenosis rarely accompanies urinary tract malformations, with only single cases reported [10]. We present a case of a teenage boy with stenosis of a renal artery supplying solitary ectopic kidney caused by urinary bladder dysfunction.

Case report

A 12-year-old boy with a complex urinary tract malformation, chronic kidney disease (CKD) stage 2, and AH was admitted to the hospital due to deterioration of kidney function. The prenatal examination revealed an absence of the right kidney in the typical position and abnormalities in the left urinary tract and kidney for further differentiation (polycystic kidney or hydronephrosis). Shortly after he was born, the left kidney was found to be typically positioned, enlarged (75 mm), and dysplastic with multiple cysts. The right ectopic kidney was located at the level of L4-L5 (lumbar vertebrae) in the body’s midline, behind the bladder, with incomplete rotation and persistent fetal lobulation. In urography, the contrast agent secretion of the right kidney was normal, and the secretory function of the left kidney was absent. Voiding cystourethrography (first week of life) revealed passive and active vesicoureteric reflux (grade 2–3) to the right kidney. Dynamic scintigraphy revealed diminished uptake and slow contrast release from the left kidney (left kidney 23%, right kidney 77%). At the age of 11 months, a left-sided nephrectomy was performed.

At the age of eight, the patient’s creatinine was 0.9 mg/dL (GFR according to Schwartz formula [11] – 62 mL/min/1.73m2), the patient was diagnosed with CKD stage 2. At that point, 24-hour ambulatory blood pressure monitoring was performed 24 h mean arterial pressure was between 95–99th percentile during the day and above 99th percentile at night enalapril 2 × 2.5 mg was implemented.

In the outpatient clinic, due to poor control of AH (blood pressure up to 150/70 mm Hg), enalapril was changed to ramipril and then to lisinopril (initially 5 mg, then 10 mg once daily). Because of the increase in creatinine concentration during treatment with angiotensin-converting enzyme inhibitor (ACE-I) to 1.1 mg/dL [glomerular filtration rate (GFR) 61.5 mL/min/1.73 m2], the boy was referred to our tertiary center of pediatric nephrology with suspicion of RVH.

The boy was hospitalized in our Department at the age of 12.5 years. His physical examination was unremarkable, his height (164 cm 75–90 percentile according to [12]) and weight (62 cm 90 percentile acc. to [12]) were within normal limits, his office blood pressure was 139/75 – 142/84 mm Hg (above 95 percentile [13]), his creatinine was 1.1 mg/dL (GFR 61.6 mL/min/1.73 m2), urea 53 mg/dL; urinalysis was normal except for low specific gravity, and urinary albumin loss was 80 mg/24 h.

In CT angiography (Fig. 1), the right ectopic kidney was located above the bladder, with incomplete rotation, supplied by a single renal artery that originated anteriorly from the right common iliac artery, below the bifurcation. The artery had an irregular, tortuous shape. The width of the artery in the ostium was about 4.5 mm; then, the artery was bent and ran between the common iliac artery and the kidney (the kidney was modeled at this level).

Skrzypczyk-1.png
Figure 1. A computed tomography (CT) angiography: right renal artery arising from the right common iliac artery with the bending and compression between the urinary bladder, right kidney, and right common iliac artery (blue arrow bending of the right renal artery)

The ultrasound performed with a filled bladder showed the bending and stenosis of the renal artery at the origin of the right common iliac artery. In the Doppler ultrasonography (Fig. 2), peak systolic velocity (PSV) was 4.5–5.5 m/s, and renal-aortic ratio (RAR) was 3.1. With an empty bladder (Fig. 3), no bending or stenosis was visible, and in the Doppler ultrasonography, there were no features of stenosis: PSV was 1.7–1.9 m/s and RAR 1.0.

Skrzypczyk-2.png
Figure 2. Doppler ultrasonography of renal artery with a filled bladder: right renal artery arising from the right common iliac artery with the bending and peak systolic velocity (PSV) 5.5 m/s.
Skrzypczyk-3.jpg
Figure 3. Doppler ultrasonography of renal artery with an empty bladder: no bending or stenosis visible

The boy was complaining about rare urination. A uroflowmetry revealed the dysfunctional micturition curve, large bladder capacity (470 mL), and post-void residual urine retention (40 mL). As the kidney function was deteriorating, ACEi was stopped. The treatment was changed for extended-release metoprolol (50 mg, once daily) with doxazosin (2 × 1.0 mg) the latter was chosen due to bladder dysfunction. Due to hyperuricemia (9.4 mg/dL), allopurinol (100 mg, once daily) was started. After administering the beta-blocker and doxazosin, blood pressure normalized and creatinine concentration decreased to 0.9 mg/dL (GFR 75.3 mL/min/1.73 m2), the voiding frequency improved.

Due to concurrent urinary tract malformation, hyperuricemia, and periodical hypomagnesemia (1.5 mg/dL), HNF1B (hepatocyte nuclear factor-1-beta) mutation was suspected, but the genetic test (next-generation sequencing, NGS) was negative.

At present, the boy is 15 years old, his creatinine is 1.1 mg/dL (GFR 65.3 mL/min/1.73 m2), blood pressure is well controlled (114/70 mm Hg) on doxazosin 2 × 1 mg.

Discussion

We present a case of renovascular hypertension, in whom the stenosis of the renal artery supplying ectopic kidney was caused by bladder dysfunction. Interestingly, the filling of the bladder with urine had a significant effect on anatomical relations and stenosis Doppler ultrasound examination revealed abnormal blood flow to the kidney only with the urinary bladder filled. As in every case of renal artery stenosis of a solitary kidney, treatment with ACEi impaired renal function. Of note, the blood pressure and kidney function stabilized once the patient was started on alpha-adrenolytic, which also acted on bladder function.

The patient has been diagnosed with a lumbar kidney located at the level of L4–L5, which reported incidence is 12% in all ectopic kidneys. In contrast, the most common pelvic ectopia constitutes 55% of all ectopic kidneys [14]. Most renal ectopia is asymptomatic, but it can present as urinary tract infections, abdominal pain, hematuria, urinary incontinence, and hypertension [15]. The symptoms can be helpful in diagnosis, but most often, the final diagnosis is made postnatally by abdominal ultrasonography and confirmed by a static 99m technetium dimercaptosuccinic acid (DMSA) scan [15]. Our patient had prenatal suspicion of a complex urinary tract defect. Postnatally, the final diagnosis was made with a combination of imaging modalities (i.e., ultrasonography, voiding cystourethrography, urography, and renal scintigraphy). Renal ectopia can coexist with other congenital urinary anomalies, of which vesicoureteral reflux is the most common one [15–17]. Its frequency ranges from 2 to 70 % in various studies; in most, it is reported at approx. 20% [15, 17]. Apart from VUR, renal ectopia can coexist with hydronephrosis, contralateral renal dysplasia, multicystic dysplastic kidney, and renal agenesis [15, 18]. The blood supply of the ectopic kidneys varies, and the renal artery usually originates from the nearest large vessels such as the common iliac artery or aorta [19]. In our patient the single renal artery arose from the right common iliac artery, just below the bifurcation.

Our patient developed AH, similar to 3.5% of patients with renal ectopia, as Mininberg et al. [18] reported. In turn, other studies didn’t show increased blood pressure in the course of renal ectopia [16, 17]. The treatment of AH in our patient was initiated by implementing angiotensin-converting enzyme inhibitors. According to the American Academy of Pediatrics 2017 and European Society of Hypertension guidelines, ACE inhibitors or angiotensin II receptor blockers (ARB) are medications of choice in patients with CKD and AH [2, 4]. In line with the ESCAPE study, present guidelines recommend lowering blood pressure in CKD patients much below the 90th percentile. In recent KDIGO guidelines, target BP is as low as below the 50th percentile [20].

Urinary tract defects, hyperuricemia, and hypomagnesemia suggest the presence of HNF1B mutation. The result of the genetic test was negative. Of note, NGS cannot categorically exclude HNF1B gene defect, and further patient follow-up is mandatory. Mutation of the HNF1B gene is typically responsible for bilateral renal cystic hypodysplasia, hyperuricemia, elevated liver enzymes, and diabetes mellitus [21]. Moreover, in some patients, it manifests with hypomagnesemia due to impaired reabsorption of magnesium in the distal tubule (Gittelman-like phenotype) [21, 22].

Fibromuscular dysplasia is a leading cause of RVH in young people, including pediatric patients. FMD can be found even in infants. In children, FMD is characterized by a high prevalence of extrarenal artery involvement [23]. However, the clinician should not forget the rare forms of RVH. Etiologic and differential diagnosis matters both for prognosis and management, as illustrated in a recent review by Persu et al. [9].

The unique feature of our patient was the origin of the renal artery stenosis. Doppler ultrasonography revealed that the filled bladder contributed substantially or even caused renal artery stenosis. Noteworthy, the patient was found to have urinary bladder dysfunction with rare micturition, increased bladder capacity, post-void urine retention, and dysfunctional micturition curve. Alpha-adrenergic receptor antagonist (doxazosin) therapy was started, and urotherapy was implemented, which resulted in increased voiding frequency and stabilization of blood pressure and renal function. Alpha-adrenergic receptor antagonists relax the smooth muscle at the bladder neck and proximal urethra. They are widely used in neurogenic and non-neurogenic bladder dysfunction in both adults and children [24, 25]. Doxazosin with non-specific action also on vascular smooth muscle cells was chosen to lower systemic bladder. Noteworthy, both adult and pediatric guidelines do not recommend alpha-adrenolytics as first-line medications without other comorbidities [1, 2].

RVH can be caused by renal artery compression by extrinsic masses, e.g., Wilms’ tumor, neuroblastoma, renal cysts, or diaphragmatic crura [8, 26]. To the best of our knowledge, this is the first reported case of RVH caused by renal artery displacement and compression by dysfunctive urinary bladder. Conversely, bladder dysfunction was revealed in an experimental model of renovascular hypertension with tissue remodeling and enhanced muscarinic M(3)-mediated contractions associated with reduced beta-adrenoceptor-mediated signal transduction [27]. The same authors showed bladder function improvement with losartan and captopril [28]. Jeronimo et al. reported a case of a 13-month-old baby with severe RVH (bilateral renal artery stenosis) that manifested with failure to thrive, recent muscular weakness of the lower extremities, and irritability. In the authors’ opinion, the patient was diagnosed with a neurogenic bladder that was most probably caused by medullary infarction caused by severe hypertension [29]. In the presented case, due to renal function, blood pressure stabilization, and extremely difficult surgical conditions and access, the patient was treated conservatively.

Conclusions

Renal ectopia associated with bladder dysfunction may result in renal artery stenosis causing renovascular hypertension.

Institutional Review Board Statement

The Local Bioethics Committee approved the study (Approval Code: AKBE/200/2021). Informed consent was obtained from the patient’s representatives for publishing the study.

Funding

This research was funded from the statutory funds of the Department of Pediatrics and Nephrology, Medical University of Warsaw.

References

  1. Williams B, Mancia G, Spiering W, et al. Authors/Task Force Members:, ESC Scientific Document Group . 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33): 3021–3104, doi: 10.1093/eurheartj/ehy339, indexed in Pubmed: 30165516.
  2. Lurbe E, Agabiti-Rosei E, Cruickshank JK, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016; 34(10): 1887–1920, doi: 10.1097/HJH.0000000000001039, indexed in Pubmed: 27467768.
  3. Gupta-Malhotra M, Banker A, Shete S, et al. Essential hypertension vs. secondary hypertension among children. Am J Hypertens. 2015; 28(1): 73–80, doi: 10.1093/ajh/hpu083, indexed in Pubmed: 24842390.
  4. Flynn J, Kaelber D, Baker-Smith C, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017; 140(3): e20171904, doi: 10.1542/peds.2017-1904, indexed in Pubmed: 28827377.
  5. Tullus K, Brennan E, Hamilton G, et al. Renovascular hypertension in children. Lancet. 2008; 371(9622): 1453–1463, doi: 10.1016/S0140-6736(08)60626-1, indexed in Pubmed: 18440428.
  6. Chung H, Lee JH, Park E, et al. Long-Term Outcomes of Pediatric Renovascular Hypertension. Kidney Blood Press Res. 2017; 42(3): 617–627, doi: 10.1159/000481549, indexed in Pubmed: 28950261.
  7. Gornik HL, Persu A, Adlam D, et al. Working Group ‘Hypertension and the Kidney’ of the European Society of Hypertension (ESH) and the Society for Vascular Medicine (SVM). First international consensus on the diagnosis and management of fibromuscular dysplasia. J Hypertens. 2019; 37(2): 229–252, doi: 10.1097/HJH.0000000000002019, indexed in Pubmed: 30640867.
  8. Villegas L, Cahill AM, Meyers K. Pediatric Renovascular Hypertension: Manifestations and Management. Indian Pediatr. 2020; 57(5): 443–451, indexed in Pubmed: 32221053.
  9. Persu A, Canning C, Prejbisz A, et al. Beyond Atherosclerosis and Fibromuscular Dysplasia: Rare Causes of Renovascular Hypertension. Hypertension. 2021; 78(4): 898–911, doi: 10.1161/HYPERTENSIONAHA.121.17004, indexed in Pubmed: 34455817.
  10. Kari JA, Roebuck DJ, Tullus K. Renal artery stenosis in association with congenital anomalies of the kidney and urinary tract. Saudi Med J. 2014; 35(10): 1264–1266, indexed in Pubmed: 25316474.
  11. Schwartz GJ, Muñoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009; 20(3): 629–637, doi: 10.1681/ASN.2008030287, indexed in Pubmed: 19158356.
  12. Kułaga Z, Litwin M, Tkaczyk M, et al. Polish 2010 growth references for school-aged children and adolescents. Eur J Pediatr. 2011; 170(5): 599–609, doi: 10.1007/s00431-010-1329-x, indexed in Pubmed: 20972688.
  13. Kułaga Z, Litwin M, Grajda A, et al. OLAF Study Group. Oscillometric blood pressure percentiles for Polish normal-weight school-aged children and adolescents. J Hypertens. 2012; 30(10): 1942–1954, doi: 10.1097/HJH.0b013e328356abad, indexed in Pubmed: 22828086.
  14. Hamano I, Hatakeyama S, Soma O, et al. Renal cell carcinoma in a lumbar ectopic kidney. IJU Case Rep. 2019; 2(3): 124–127, doi: 10.1002/iju5.12056, indexed in Pubmed: 32743390.
  15. Guarino N, Tadini B, Camardi P, et al. The incidence of associated urological abnormalities in children with renal ectopia. J Urol. 2004; 172(4 Pt 2): 1757–9; discussion 1759, doi: 10.1097/01.ju.0000138376.93343.74, indexed in Pubmed: 15371807.
  16. van den Bosch CMA, van Wijk JAE, Beckers GMA, et al. Urological and nephrological findings of renal ectopia. J Urol. 2010; 183(4): 1574–1578, doi: 10.1016/j.juro.2009.12.041, indexed in Pubmed: 20172541.
  17. Dogan CS, Dorterler ME, Aybar MD, et al. Associated anomalies and clinical outcome in children with ectopic kidney. Saudi J Kidney Dis Transpl. 2017; 28(2): 330–335, doi: 10.4103/1319-2442.202787, indexed in Pubmed: 28352016.
  18. Mininberg DT, Roze S, Pearl M. Hypertension associated with crossed renal ectopia in an infant. Pediatrics. 1971; 48(3): 454–457, indexed in Pubmed: 5094348.
  19. Kara E, Oztürk NC, Ozgür A, et al. Ectopic kidney with varied vasculature: demonstrated by CT angiography. Surg Radiol Anat. 2011; 33(1): 81–84, doi: 10.1007/s00276-010-0684-7, indexed in Pubmed: 20556387.
  20. Cheung AK, Chang TI, Cushman WC, et al. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021; 99(3S): S1–S87, doi: 10.1016/j.kint.2020.11.003, indexed in Pubmed: 33637192.
  21. Okorn C, Goertz A, Vester U, et al. HNF1B nephropathy has a slow-progressive phenotype in childhood-with the exception of very early onset cases: results of the German Multicenter HNF1B Childhood Registry. Pediatr Nephrol. 2019; 34(6): 1065–1075, doi: 10.1007/s00467-018-4188-8, indexed in Pubmed: 30666461.
  22. Adalat S, Hayes WN, Bryant WA, et al. HNF1B Mutations Are Associated With a Gitelman-like Tubulopathy That Develops During Childhood. Kidney Int Rep. 2019; 4(9): 1304–1311, doi: 10.1016/j.ekir.2019.05.019, indexed in Pubmed: 31517149.
  23. Obrycki Ł, Sarnecki J, Sobczyk K, et al. High prevalence of extrarenal artery involvement in children with fibromuscular dysplasia - a single-center experience. J Hypertens. 2021; 39(12): 2439–2445, doi: 10.1097/HJH.0000000000002957, indexed in Pubmed: 34516057.
  24. Cain MP, Wu SD, Austin PF, et al. Alpha blocker therapy for children with dysfunctional voiding and urinary retention. J Urol. 2003; 170(4 Pt 2): 1514–5; discussion 1516, doi: 10.1097/01.ju.0000085961.27403.4a, indexed in Pubmed: 14501648.
  25. Donohoe JM, Combs AJ, Glassberg KI. Primary bladder neck dysfunction in children and adolescents II: results of treatment with alpha-adrenergic antagonists. J Urol. 2005; 173(1): 212–216, doi: 10.1097/01.ju.0000135735.49099.8c, indexed in Pubmed: 15592078.
  26. Mirza AK, Kendrick ML, Bower TC, et al. Renovascular hypertension secondary to renal artery compression by diaphragmatic crura. J Vasc Surg Cases Innov Tech. 2020; 6(2): 239–242, doi: 10.1016/j.jvscit.2020.03.002, indexed in Pubmed: 32490294.
  27. Ramos-Filho ACS, Mónica FZT, Franco-Penteado CF, et al. Characterization of the urinary bladder dysfunction in renovascular hypertensive rats. Neurourol Urodyn. 2011; 30(7): 1392–1402, doi: 10.1002/nau.21074, indexed in Pubmed: 21661033.
  28. Ramos-Filho AC, Moscoso JA, Calmasini F, et al. Blockade of renin-angiotensin system prevents micturition dysfunction in renovascular hypertensive rats. Eur J Pharmacol. 2014; 738: 285–292, doi: 10.1016/j.ejphar.2014.05.038, indexed in Pubmed: 24881522.
  29. Jerónimo M, Dionísio T, Gomes C, et al. Renovascular hypertension: a case with atypical neurological signs. BMJ Case Rep. 2015; 2015, doi: 10.1136/bcr-2014-208336, indexed in Pubmed: 26351310.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl